0000899243-22-036936.txt : 20221123 0000899243-22-036936.hdr.sgml : 20221123 20221123163111 ACCESSION NUMBER: 0000899243-22-036936 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221122 FILED AS OF DATE: 20221123 DATE AS OF CHANGE: 20221123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Topper David Joseph CENTRAL INDEX KEY: 0001740378 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39765 FILM NUMBER: 221416734 MAIL ADDRESS: STREET 1: C/O GENERAL ATLANTIC SERVICE COMPANY, LP STREET 2: 55 EAST 52ND STREET, 32ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10055 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frazier Lifesciences Acquisition Corp CENTRAL INDEX KEY: 0001828326 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO UNION SQUARE, 601 UNION STREET STREET 2: SUITE 3200 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 617-570-8364 MAIL ADDRESS: STREET 1: TWO UNION SQUARE, 601 UNION STREET STREET 2: SUITE 3200 CITY: SEATTLE STATE: WA ZIP: 98101 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-22 1 0001828326 Frazier Lifesciences Acquisition Corp FLAC 0001740378 Topper David Joseph C/O FRAZIER LIFESCIENCES ACQUISITION TWO UNION SQUARE, 601 UNION ST. STE 3200 SEATTLE WA 98101 1 1 0 0 Chief Financial Officer Class B Ordinary Shares 2022-11-22 4 M 0 30000 D Class A Ordinary Shares 30000 0 D Pursuant to the terms outlined in the Business Combination Agreement, dated July 25, 2022, by and among NewAmsterdam Pharma Holding B.V., Frazier Lifesciences Acquisition Corporation, NewAmsterdam Pharma Investment Corporation, and NewAmsterdam Pharma Company B.V., these shares were automatically converted into Class A ordinary shares of NewAmsterdam Pharma Company N.V. (Nasdaq symbol "NAMS"). The Business Combination closed on November 22, 2022. /s/ David Topper 2022-11-23